Delivery Order SPE2DB24D1205-SPE2DB24FCQZZ
Award Date 5/3/24
Potential Completion Date 5/6/24
Potential Value $5.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Bupropion HCL XL 150 mg tablets to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp. The fixed-price delivery order, valued at $1,183.14, has a completion date of February 15, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,698.91 for the provision of 4,562,939,577 units of Bupropion HCL XL 300 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of November 30, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of Bupropion HCL XL 150 mg tablets in 500-count size, with a ceiling value of $10,602.74 and a period of performance through March 22, 2024. The contract is a firm fixed price delivery order, with no set-aside designation used....
- This federal contract award, valued at $13,605.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen, a major pharmaceutical distribution company, was awarded this firm-fixed-price delivery order for the supply of 4,564,542,994 units of Bupropion HCl XL 300 mg tablets. The award does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $21,044.34 for 4563775004 - Bupropion HCL XL 300 mg tablets. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD) that provides medical supplies and pharmaceuticals to the military and veterans' healthcare systems. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) with a ceiling value of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a delivery order for Bupropion HCL XL 150 mg tablets worth $8,900.78. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical valued at $13,969.24. The contract provides for the delivery of 4,564,110 units of Bupropion HCl XL 150 mg tablets by March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,366.13 firm fixed-price delivery order is for the supply of 4,563,851,552 units of Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of March 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the U.S. Department of Defense's Medical Supply Chain agency to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Bupropion HCL XL 300 mg tablets. The firm-fixed-price delivery order, valued at $44,120.07, has an ultimate completion date of April 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
- This federal contract award is for the delivery of pharmaceutical products, specifically BUPROPION HCL XL 300 MG TABLET, to the Defense Logistics Agency (DLA). The $86,987.29 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 16, 2023, with a completion date of November 17, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical...